Thymosin alpha-1

Thymosin Alpha-1 (Tα1): Details & Benefits 1. Basic Introduction Thymosin alpha-1 (Tα1) is a 28-amino-acid bioactive peptide (molecular weight: ~3 kDa) naturally produced by thymic epithelial cells. It is derived from the cleavage of prothymosin α (ProTα), a 109–113 amino acid precursor protein. Generic name : Thymalfasin Brand name : Zadaxin (approved in 35+ countries) Discovery : First isolated from thymus tissue in 1966; fully sequenced and synthesized in the 1970s. 2. Core Mechanism of Action Tα1 acts as a potent immune modulator by targeting toll-like receptors (TLR2, TLR3, TLR4, TLR9) on immune cells (dendritic cells, macrophages, T/B cells, NK cells): Promotes T-cell development : Drives differentiation of immature T cells into CD4⁺ helper and CD8⁺ cytotoxic T cells. Boosts innate immunity : Activates NK cells and macrophages to enhance pathogen/killer cell activity. Stimulates cytokine release : Increases production of IFN-γ, IL-2, IL-3, and TNF-α, amplifying immune signaling. Restores immune homeostasis : Balances immune responses, suppressing excessive inflammation while fighting infection. 3. Key Benefits & Therapeutic Uses ① Antiviral Activity Hepatitis B/C : Approved in many countries for chronic hepatitis B/C; enhances viral clearance by restoring T-cell immunity (often combined with interferon). COVID-19 & Other Viruses : Reduces severity and mortality in viral infections by reversing virus-induced T-cell exhaustion. ② Antitumor Adjuvant Chemo/Radiotherapy Support : Protects bone marrow and immune cells from cytotoxic damage; reduces side effects (e.g., myelosuppression) and improves quality of life. Immunotherapy Synergy : Enhances efficacy of PD-1/PD-L1 inhibitors by reversing tumor microenvironment immunosuppression. Anti-metastatic : Inhibits tumor cell migration and angiogenesis; induces apoptosis in cancer cells. ③ Immune Deficiency & Aging Immune Senescence : Restores thymic function in elderly individuals, reversing age-related immune decline. Chronic Infections : Treats recurrent bacterial/fungal infections in immunocompromised patients (e.g., post-surgery, HIV). ④ Anti-Inflammatory & Organ Protection Autoimmune Diseases : Modulates Treg cells to suppress overactive immunity in conditions like rheumatoid arthritis. Organ Injury : Protects liver, lung, and kidney tissues from oxidative stress and inflammation. 4. Safety & Administration Route : Subcutaneous injection (most common); intravenous infusion. Side Effects : Mild and rare (injection site redness, fatigue, headache); no severe toxicity reported. Contraindications : Hypersensitivity to Tα1; active autoimmune disease (uncontrolled). 5. Summary Thymosin alpha-1 is a multifunctional immune peptide with decades of clinical validation. Its core value lies in restoring, enhancing, and balancing immunity , making it a cornerstone therapy for viral infections, cancer supportive care, and immune deficiency disorders.